DOTAP-Based Hybrid Nanostructured Lipid Carriers for CRISPR-Cas9 RNP Delivery Targeting &lt;i&gt;TGFB1&lt;/i&gt; in Diabetic Nephropathy. Here, TGFB1 is linked to diabetic kidney disease.